These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
530 related articles for article (PubMed ID: 11682505)
1. Application of virus-specific immunoglobulin M (IgM), IgG, and IgA antibody detection with a polyantigenic enzyme-linked immunosorbent assay for diagnosis of Epstein-Barr virus infections in childhood. Schaade L; Kleines M; Häusler M J Clin Microbiol; 2001 Nov; 39(11):3902-5. PubMed ID: 11682505 [TBL] [Abstract][Full Text] [Related]
2. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status]. De Ory F; Guisasola ME; Sanz JC; García-Bermejo I Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):618-20. PubMed ID: 22854635 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of a multiplex fluorescent microsphere immunoassay for the determination of epstein-barr virus serologic status. Martins TB; Litwin CM; Hill HR Am J Clin Pathol; 2008 Jan; 129(1):34-41. PubMed ID: 18089487 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies]. Altuğlu I; Aksoy A; Zeytinoğlu A; Orman M Mikrobiyol Bul; 2010 Apr; 44(2):231-6. PubMed ID: 20549957 [TBL] [Abstract][Full Text] [Related]
5. An evaluation of a polyantigenic ELISA to detect Epstein-Barr virus reactivation. Gutiérrez J; Rodríguez M; Soto MJ; Suarez S; Morales P; Piédrola G; Maroto MC Microbios; 2001; 106(413):49-54. PubMed ID: 11491524 [TBL] [Abstract][Full Text] [Related]
6. Clinical reliability of IgG, IgA, and IgM antibodies in detecting Epstein-Barr virus at different stages of infection with a commercial nonrecombinant polyantigenic ELISA. Gutiérrez J; Vergara MJ; Piédrola G; Maroto MC J Clin Lab Anal; 1999; 13(2):65-8. PubMed ID: 10102134 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Epstein-Barr virus antibodies, anti-VCA avidity by immunofluorescence and immunoblot assays for assessment of Epstein-Barr virus immunologic state. Sener AG; Afsar I; Pinar E J Virol Methods; 2009 Aug; 159(2):300-2. PubMed ID: 19406156 [TBL] [Abstract][Full Text] [Related]
8. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit]. Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576 [TBL] [Abstract][Full Text] [Related]
9. A systematic study of Epstein-Barr virus serologic assays following acute infection. Rea TD; Ashley RL; Russo JE; Buchwald DS Am J Clin Pathol; 2002 Jan; 117(1):156-61. PubMed ID: 11789721 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children. Votava M; Bartosová D; Krchnáková A; Crhová K; Kubinová L Acta Virol; 1996 Apr; 40(2):99-101. PubMed ID: 8886119 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status. Klutts JS; Liao RS; Dunne WM; Gronowski AM J Clin Microbiol; 2004 Nov; 42(11):4996-5000. PubMed ID: 15528686 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of IgG-IgM antibodies against the Epstein-Barr virus nuclear antigen (EBNA-1) using ELISA]. Martínez Zapico R; Sobejano L; Llamazares I; Ladrón de Guevara C Enferm Infecc Microbiol Clin; 1992 May; 10(5):281-3. PubMed ID: 1327168 [TBL] [Abstract][Full Text] [Related]
13. Comparison of immunofluorescence assay and multiplexed microparticle-based immunoassay for detecting Epstein-Barr virus viral capsid antigen antibodies. Zeytinoglu A; Altuglu I; Karatas E; Yazan Sertoz R J Virol Methods; 2008 Mar; 148(1-2):300-2. PubMed ID: 18215427 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method. Corrales I; Giménez E; Navarro D Clin Vaccine Immunol; 2014 May; 21(5):684-8. PubMed ID: 24623623 [TBL] [Abstract][Full Text] [Related]
15. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18. Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic evaluation of a new panel of assays for Epstein-Barr virus serology. Radtke M; Gärtner B; Franke D Clin Lab; 2007; 53(3-4):149-50. PubMed ID: 17447650 [No Abstract] [Full Text] [Related]
17. Comparison of a multiplexed bead-based assay with an immunofluorescence and an enzyme-immuno assay for the assessment of Epstein-Barr virus serologic status. Devanthéry O; Meylan P Clin Microbiol Infect; 2010 Dec; 16(12):1776-82. PubMed ID: 20219083 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of three different assays for the assessment of Epstein Barr Virus immunological status. Altuglu I; Bozkurt H; Samlioglu P; Zeytinoglu A New Microbiol; 2007 Oct; 30(4):393-8. PubMed ID: 18080674 [TBL] [Abstract][Full Text] [Related]
19. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486 [TBL] [Abstract][Full Text] [Related]
20. [Purification and application of viral capsid antigen of Epstein-Barr virus]. Zhou W; Gu S Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):252-5. PubMed ID: 15617341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]